West Pharmaceutical Services (WST) Fell on Lowered Guidance
In its first-quarter 2025 investor letter, Parnassus Mid Cap Growth Fund highlighted stocks such as West Pharmaceutical Services, Inc. (NYSE:WST). West Pharmaceutical Services, Inc. (NYSE:WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. The one-month return of West Pharmaceutical Services, Inc. (NYSE:WST) was 4.63%, and its shares lost 31.06% of their value over the last 52 weeks. On July 2, 2025, West Pharmaceutical Services, Inc. (NYSE:WST) stock closed at $221.22 per share with a market capitalization of $15.894 billion.
Parnassus Mid Cap Growth Fund stated the following regarding West Pharmaceutical Services, Inc. (NYSE:WST) in its Q1 2025 investor letter:
"West Pharmaceutical Services, Inc. (NYSE:WST), a leader in packaging for injectable therapies, declined after lowering guidance due to ongoing customer destocking. While the core injectable components business remains strong, the surprise exit by two major customers in their contract manufacturing business added uncertainty."
A closeup of multiple drug containment systems in an array of colors.
West Pharmaceutical Services, Inc. (NYSE:WST) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held West Pharmaceutical Services, Inc. (NYSE:WST) at the end of the first quarter, which was 35 in the previous quarter. While we acknowledge the potential of West Pharmaceutical Services, Inc. (NYSE:WST) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains.
In another article, we covered West Pharmaceutical Services, Inc. (NYSE:WST) and shared Baron Asset Fund's views on the company. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of WST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Game-Changing HSA Reforms Just Passed—Here's What It Means for Healthcare
SAN FRANCISCO--(BUSINESS WIRE)--Today, Lively, Inc. marks the signature of the 'One Big Beautiful Bill' (OBBB) into law, a major bill that expands access and flexibility for Health Savings Accounts (HSAs). Under the new law, millions of Americans enrolled in Bronze or Catastrophic ACA plans are now eligible to contribute to HSAs starting January 1, 2026, and key innovations like telehealth services and Direct Primary Care are officially HSA-qualified expenses. Game-Changing HSA Reforms Just Passed—Here's What It Means for Healthcare: Landmark legislation enables HSA use with Bronze/Catastrophic ACA plans, telehealth, and direct primary care—bringing healthcare savings into the modern era. Share Lively, a top-rated health and lifestyle benefits platform* known for building the modern Health Savings Account (HSA), is uniquely positioned to support individuals, employers, and brokers navigating this new era. Lively's platform already connects with over 95% of U.S. health plans and integrates seamlessly with Direct Primary Care models and virtual-first providers. 'In a world of rising out-of-pocket costs, HSAs are the most powerful way to take control of US consumer healthcare finances. This isn't just a policy shift—it's a redefinition of how Americans can save, spend, and stay healthy," said Alex Cyriac, CEO and co-founder of Lively. 'At Lively, we've built a platform that's flexible, intelligent, and ready for this next generation of benefits.' What's Changing: HSA Eligibility Opens for Millions of Americans: Enrollees in Bronze and Catastrophic ACA plans are now eligible and can contribute to HSAs. Modern Care Models Included: HSA funds can be used for Direct Primary Care arrangements. Telehealth Flexibility Made Permanent: First-dollar coverage for telehealth services no longer disqualifies HSA status. How Lively Helps: No Hidden Fees - Your healthcare shouldn't come at a hidden cost — Lively HSAs are free for individuals and families. Get Started in Minutes: Confirm your eligibility and open an HSA account instantly. Smart Claim Sync: Automatically syncs with employee health plan data, including high-deductible, Bronze, and Catastrophic plans. Built for Innovation: Already supports virtual-first, Direct Primary Care (DPC), and hybrid health plan designs. About Lively Lively is the health and lifestyle benefits provider that gets it right. Our solutions are designed to take the guesswork out of managing benefits and drive efficiency for HR teams. Our innovative platform combines robust features with unparalleled service, to make maximizing your benefits as simple as it should be. Lively currently offers HSA, FSA, HRA, COBRA, Direct Bill, Commuter, Lifestyle Spending Accounts, and Medical Travel Accounts.
Business Wire
2 hours ago
- Business Wire
OLO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olo Inc.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Olo Inc. (NYSE: OLO) to Thoma Bravo. Under the terms of the proposed transaction, shareholders of Olo will receive $10.25 in cash for each share of Olo that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit
Business Wire
4 hours ago
- Business Wire
COMPASS DIVERSIFIED 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Compass Diversified Holdings
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)-- Kahn Swick & Foti, LLC ('KSF') and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until to file lead plaintiff applications in securities class action lawsuits against Compass Diversified Holdings (NYSE: CODI), if they purchased the Company's securities between March 1, 2023 and May 7, 2025, inclusive (the 'Class Period'). These actions are pending in the United States District Court for the Central District of California. What You May Do If you purchased securities of Compass and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ( or visit to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by July 8, 2025. About the Lawsuits Compass and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On May 7, 2025, the Company issued a press release entitled "Compass Diversified Discloses Non-Reliance on Financial Statements for Fiscal 2024 Amid an Ongoing Internal Investigation into its Subsidiary, Lugano Holding, Inc.," disclosing that 'the Audit Committee of CODI's Board has concluded that the previously issued financial statements for 2024 require restatement and should no longer be relied upon' and that '[e]ffective May 7, 2025, Lugano's founder and CEO, Moti Ferder, resigned from all of his positions at Lugano and will not receive any severance compensation.' The Company further disclosed that '[t]he Audit Committee of CODI's Board of Directors promptly launched an investigation after CODI's senior leadership was made aware of concerns about how Lugano was potentially financing inventory' and that '[t]he investigation . . . is ongoing but has preliminarily identified irregularities in Lugano's non-CODI financing, accounting, and inventory practices.' On this news, the price of Compass' shares plummeted approximately 62%, from $17.25 per share on May 7, 2025, to $6.55 per share on May 8, 2025. The case is Matthews v. Compass Group Diversified Holdings, Inc., et al., No. 25-cv-981. A subsequent case, Tan v. Compass Group Diversified Holdings, Inc., et al., No. 25-cv-5777, extended the class period. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg. To learn more about KSF, you may visit
